Vhb Medi Sciences Limited

Produces injectables and other pharmaceutical products, pending FDA certification.

2007 | Mumbai, Maharashtra (India) | Active
Last Updated: December 21, 2024

Vhb Medi Sciences Profile

Key Indicators

  • Authorised Capital ₹ 25.00 Cr
  • Paid Up Capital ₹ 12.75 Cr
  • Company Age 17 Year, 4 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 4.90 Cr
  • Satisfied Charges ₹ 185.51 Cr
  • Revenue Growth 105.59%
  • Profit Growth 188.93%
  • Ebitda 1136.62%
  • Net Worth 141.38%
  • Total Assets 3.92%

About Vhb Medi Sciences

Vhb Medi Sciences Limited (VMSL) is a leading Public Limited Indian Non-Government Company incorporated in India on 12 September 2007 and has a history of 17 years and four months. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Pharma Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 12.75 Cr.

The company currently has active open charges totaling ₹4.90 Cr. The company has closed loans amounting to ₹185.51 Cr, as per Ministry of Corporate Affairs (MCA) records.

The Key Managerial Personnel (KMP) at Vhb Medi Sciences Limited India are Neha Jain as COMPANY SECRETARY and Rohan Ashok as Cfo. Uttamchand Jain, Pravin Jain, Rahul Jain, and One other member serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address
  • Social Media
    -

Corporate Identity Details

  • CIN/LLPIN

    U24232MH2007PLC174054

  • Company No.

    174054

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    12 Sep 2007

  • Date of AGM

    26 Sep 2024

  • Date of Balance Sheet

    31 Mar 2024

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Pharma

Who are the key members and board of directors at Vhb Medi Sciences?

Executive Team (2)

NameDesignationAppointment DateStatus
Neha Jain Country flag representing In Company Secretary29-Aug-2023Current
Rohan Ashok Country flag representing In CFO01-Jul-2019Current

Board Members (4)

NameDesignationAppointment DateStatus
Uttamchand Jain Country flag representing In Director 27-Sep-2012Current
Pravin Jain Country flag representing In Director 27-Sep-2012Current
Rahul Jain Country flag representing In Director 27-Sep-2012Current
Ashokkumar Jain Country flag representing In Whole-Time Director 27-Sep-2012Current

Financial Performance of Vhb Medi Sciences.

Vhb Medi Sciences Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 105.59% increase. The company also saw a substantial improvement in profitability, with a 188.93% increase in profit. The company's net worth Soared by an impressive increase of 141.38%.

Graph illustrating revenue growth over time
Graph showing profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
105.59%
Revenue from Operations
106.29%
Total Assets
3.92%
Profit or Loss
188.93%
Net Worth
141.38%
EBITDA
1136.62%

What is the Ownership and Shareholding Structure of Vhb Medi Sciences?

In 2022, Vhb Medi Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Open Charges

₹4.90 Cr

Satisfied Charges

₹185.51 Cr

Charges Breakdown by Lending Institutions

  • Others : 4.90 Cr

Latest Charge Details

DateLenderAmountStatus
09 Apr 2009Others₹4.90 CrOpen
23 Oct 2010Bank Of Baroda₹2.00 CrSatisfied
19 Dec 2009Bank Of Baroda₹0.72 MSatisfied
11 Jul 2009Bank Of Baroda₹3.00 CrSatisfied
09 Apr 2009Bank Of Baroda₹116.34 CrSatisfied

How Many Employees Work at Vhb Medi Sciences?

Vhb Medi Sciences has a workforce of 240 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Graph showing employee growth trends

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Vhb Medi Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vhb Medi Sciences's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Vhb Medi Sciences

Recent activity within the organization

  • Annual General Meeting

    Vhb Medi Sciences Limited last Annual general meeting of members was held on 26 Sep 2024 as per latest MCA records.

    26 Sep 2024

  • Balance Sheet

    Vhb Medi Sciences Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai.

    31 Mar 2024

  • Director Appointment

    Neha Jain was appointed as a Company Secretary was appointed as a Company Secretary on 29 Aug 2023 & has been associated with this company since 1 year 5 months .

    29 Aug 2023

  • Charges

    A charge with Others of Rs. 4.90 Cr registered on 09 Apr 2009 with Charge ID 10155427 was modified on 07 Apr 2021.

    07 Apr 2021

  • Charges

    A charge registered on 19 Dec 2009 via Charge ID 10200373 with Bank Of Baroda was fully satisfied on 18 Nov 2019.

    18 Nov 2019

  • Charges

    A charge registered on 09 Apr 2009 via Charge ID 10155426 with Bank Of Baroda was fully satisfied on 18 Nov 2019.

    18 Nov 2019

Frequently asked questions

  • Vhb Medi Sciences Limited was incorporated on 12 Sep 2007.

  • The authorized share capital of Vhb Medi Sciences Limited is ₹ 25.00 Cr and paid-up capital is ₹ 12.75 Cr.

  • Currently 6 directors are associated with Vhb Medi Sciences Limited.

    • Uttamchand Kesharimal Jain
    • Pravin Keshrimal Jain
    • Rahul Ashokkumar Jain
    • Neha Jain
    • Rohan Jain Ashok
    • Ashokkumar Keshrimal Jain
  • As per Ministry of Corporate Affairs (Mca), the registered address of Vhb Medi Sciences Limited is 50 Ab Government(Erstwhile Kandivali Co-Operative) Industrial Estate Charkop (W ), India, Mumbai, Maharashtra, 400067.

  • The corporate identification number (CIN) of Vhb Medi Sciences Limited is U24232MH2007PLC174054 and the company number is 174054 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Vhb Medi Sciences Limited is https://www.vhbgroup.com

  • According to the financial reports for the fiscal year 2022, the revenue trend for Vhb Medi Sciences Limited has risen by 105.59%.

  • As Per 2022 financial reports, 240 employees are currently employed by Vhb Medi Sciences Limited.

  • The financial reports for the fiscal year 2022 indicates that The net worth of Vhb Medi Sciences Limited has experienced an upsurge of 141.38%.

  • As per the financial statements for fiscal Year 2022, The total open charges for Vhb Medi Sciences Limited amount to ₹ 4.90 Cr.

  • The most recent Balance Sheet for Vhb Medi Sciences Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Drug Formulation & Development